.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown varied performance across different product categories in Ohio. In the Concentrates category, the brand experienced a significant decline, dropping from 11th place in January 2025 to 26th by April. This downward trend is reflected in their sales, which saw a noticeable decrease over the same period. On the other hand, their performance in the Flower category has been relatively stable, maintaining a position within the top 35 throughout the first four months of the year, with a slight improvement in April. This consistency in the Flower category suggests a steady consumer base despite fluctuating sales volumes.
In contrast, Farmaceutical Rx (Frx) has struggled to make a notable impact in the Edible and Vapor Pens categories in Ohio. The brand did not rank in the top 30 for Edibles in January, and while they entered the rankings in February, they remained outside the top 40, indicating limited market penetration in this segment. Similarly, their presence in the Vapor Pens category has been inconsistent, with rankings fluctuating and eventually disappearing from the top 30 by April. This inconsistency in the Vapor Pens category may point to challenges in capturing market share or sustaining consumer interest over time. Overall, while Farmaceutical Rx (Frx) has demonstrated some strengths, particularly in the Flower category, there are clear areas for improvement to enhance their market presence across other product lines.
Competitive Landscape
In the competitive landscape of the Ohio flower category, Farmaceutical Rx (Frx) has experienced fluctuating rankings, reflecting a dynamic market presence. In January 2025, Frx was ranked 35th, but it improved its position to 28th in February. However, by March and April, it settled at 31st and 30th, respectively. This indicates a relatively stable performance amidst a competitive field. Notably, Neighborgoods consistently outperformed Frx, maintaining a higher rank from January to March before dropping to 32nd in April, which could suggest a temporary dip in their sales. Meanwhile, Willie's Reserve and Triple Seven (777) also showed varying ranks, with Willie's Reserve starting strong at 15th in January but dropping out of the top 20 by February, while Triple Seven made a notable leap to 20th in March before falling again. These shifts highlight the competitive pressures Frx faces, emphasizing the need for strategic positioning to enhance its market share in Ohio's flower segment.
Notable Products
In April 2025, the top-performing product for Farmaceutical Rx (Frx) was Milkbone (2.83g) in the Flower category, maintaining its number one rank from January and March, with a notable sales figure of 1998.0 units. Wedding Cake (2.83g) climbed to the second position, improving from its third rank in February, indicating an upward trend in popularity. White Truffle (2.83g) rose to third place after being fourth in March, showing a steady increase in demand. Milkbone Smalls (14.15g) dropped from second in March to fourth in April, suggesting a decrease in consumer preference. Purple Ghost (2.83g) entered the rankings at fifth place, marking its debut in the top five for the first time this year.
```Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
